PHGDH Inhibition Confers a Targetable Glutamine Dependency in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) develops in a nutrient-poor microenvironment and progresses from pancreatic intraepithelial neoplasia (PanIN) to invasive carcinoma. Serine metabolism supports tumor growth in many cancers, spurring the development of inhibitors of phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in serine biosynthesis. However, the limited clinical success of PHGDH inhibitors highlights the need to better understand the stage-specific role of de novo serine synthesis during PDAC progression. Here, we showed that PHGDH increases progressively from PanIN to invasive PDAC in human and mouse tissues. In genetically engineered mouse models with inducible PHGDH knockdown, PHGDH loss delayed PDAC development. Acute treatment with the PHGDH inhibitor BI-9593 suppressed de novo serine synthesis, induced cell death, and drove tumor regression. Unexpectedly, PHGDH-deficient tumors did not become more dependent on exogenous serine, and dietary serine/glycine manipulation did not affect tumor development. Instead, stable isotope tracing and metabolomic profiling showed that PHGDH loss reduced ASCT2 expression and impaired glutamine uptake and utilization, creating a metabolic liability that rendered PHGDH-deficient tumors selectively sensitive to the glutamine antagonist DRP-104. Together, these findings reveal a therapeutic vulnerability to combined metabolic targeting in PDAC.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-11-19
DOI
https://doi.org/10.1158/0008-5472.can-26-1484
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PHGDH Inhibition Confers a Targetable Glutamine Dependency in Pancreatic Cancer

Samantha Caldwell, Matthew Long, Kenneth P. Olive, H. Carlo Maurer et al.
1 links
Cancer Research
Cancer, Hypoxia, and Metabolism
article

PHGDH Inhibition Confers a Targetable Glutamine Dependency in Pancreatic Cancer

Samantha Caldwell, Matthew Long, Kenneth P. Olive, H. Carlo Maurer, Florian A. Karreth, Gina M. DeNicola, Yumi Kim, Le Jin Sun
article en

Abstract

Pancreatic ductal adenocarcinoma (PDAC) develops in a nutrient-poor microenvironment and progresses from pancreatic intraepithelial neoplasia (PanIN) to invasive carcinoma. Serine metabolism supports tumor growth in many cancers, spurring the development of inhibitors of phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in serine biosynthesis. However, the limited clinical success of PHGDH inhibitors highlights the need to better understand the stage-specific role of de novo serine synthesis during PDAC progression. Here, we showed that PHGDH increases progressively from PanIN to invasive PDAC in human and mouse tissues. In genetically engineered mouse models with inducible PHGDH knockdown, PHGDH loss delayed PDAC development. Acute treatment with the PHGDH inhibitor BI-9593 suppressed de novo serine synthesis, induced cell death, and drove tumor regression. Unexpectedly, PHGDH-deficient tumors did not become more dependent on exogenous serine, and dietary serine/glycine manipulation did not affect tumor development. Instead, stable isotope tracing and metabolomic profiling showed that PHGDH loss reduced ASCT2 expression and impaired glutamine uptake and utilization, creating a metabolic liability that rendered PHGDH-deficient tumors selectively sensitive to the glutamine antagonist DRP-104. Together, these findings reveal a therapeutic vulnerability to combined metabolic targeting in PDAC.

Cancer Research
Columbia University Irving Medical Center (US), Moffitt Cancer Center (US)
Pancreatic Cancer Action Network, Moffitt Cancer Center, National Institutes of Health, National Cancer Institute
Good health and well-being
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon